Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Burden and quality of life in caregivers of persons with multiple sclerosis.
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
Use and medicalization of marihuana in cancer patients.
Commentary on "Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"
Reproduction and the risk of multiple sclerosis.
Depression screening in Black Americans with multiple sclerosis.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
A dorsiflexion assist orthosis reduces the physiological cost and mitigates deterioration in strength and balance associated with walking in people with Multiple Sclerosis.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.

Pages